274 related articles for article (PubMed ID: 33254097)
1. Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia.
Jacobsen DP; Lekva T; Moe K; Fjeldstad HES; Johnsen GM; Sugulle M; Staff AC
J Reprod Immunol; 2021 Feb; 143():103249. PubMed ID: 33254097
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.
Villa PM; Hämäläinen E; Mäki A; Räikkönen K; Pesonen AK; Taipale P; Kajantie E; Laivuori H
BMC Pregnancy Childbirth; 2013 May; 13():110. PubMed ID: 23663420
[TBL] [Abstract][Full Text] [Related]
4. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
He Y; Chen S; Huang H; Chen Q
J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the expression of human leukocyte antigen G and preeclampsia].
Zhao SC; Li ZB; He TQ; Yu CZ
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):758-62. PubMed ID: 22321350
[TBL] [Abstract][Full Text] [Related]
6. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
[TBL] [Abstract][Full Text] [Related]
7. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
8. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
9. The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.
Ngene NC; Moodley J; Naicker T
PLoS One; 2019; 14(4):e0215807. PubMed ID: 31022243
[TBL] [Abstract][Full Text] [Related]
10. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
11. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
13. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
[TBL] [Abstract][Full Text] [Related]
14. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
[TBL] [Abstract][Full Text] [Related]
15. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?
Neuman RI; Figaroa AMJ; Nieboer D; Saleh L; Verdonk K; Danser AHJ; Duvekot HJJ; van den Meiracker AH; Roeters van Lennep J; Visser W
Pregnancy Hypertens; 2021 Mar; 23():116-122. PubMed ID: 33321329
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA-G concentrations in obese women during pregnancy and in cord blood.
Beneventi F; Locatelli E; De Amici M; Martinetti M; Spinillo A
J Reprod Immunol; 2017 Feb; 119():31-37. PubMed ID: 27984763
[TBL] [Abstract][Full Text] [Related]
18. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
[TBL] [Abstract][Full Text] [Related]
20. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Arai F; Watanabe T; Kario K; Suzuki M
Hypertens Res; 2007 Feb; 30(2):151-9. PubMed ID: 17460385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
